Basic Sinequan Information

• INN (International Nonproprietary Name): Doxepin
• Brand Names Available In Australia: Doquel (Aspen)
• ATC Code: N06AA12
• Forms & Dosages: Capsules 10 mg, 25 mg, 50 mg, 75 mg, 100 mg; Oral solution 10 mg/mL; Tablets 3 mg and 6 mg (Silenor for insomnia)
• Manufacturers In Australia: Aspen supplies Doquel; generics also supplied by manufacturers such as Mylan and Teva (market availability varies)
• Registration Status In Australia: Registered as prescription-only medicine (Rx)
• OTC / Rx Classification: Prescription only (Rx)

Latest Research Highlights

People ask whether doxepin is still useful and safe compared with modern antidepressants.

Evidence summaries and clinical reviews emphasise two distinct uses of doxepin depending on dose.

At low nightly doses (3–6 mg), doxepin formulations such as Silenor provide sedative benefit for insomnia with minimal systemic antidepressant exposure.

At antidepressant doses doxepin acts as a tricyclic antidepressant with effectiveness comparable to older agents, but with higher anticholinergic and cardiac risk than many SSRIs.

Australian pharmacovigilance highlights the anticholinergic burden and a higher fall risk among older people taking TCAs including doxepin.

Cardiac safety concerns, including arrhythmias, are noted at higher therapeutic doses and in overdose situations.

Hepatic impairment requires cautious titration because metabolism is altered and adverse effects can increase.

Regulatory notes distinguish low‑dose insomnia tablets (Silenor) from standard doxepin antidepressant capsules such as Doquel available in Australia.

Market data show generics and branded products remain available internationally, but routine first‑line use for depression has declined in favour of SSRIs.

Clinicians interpreting the literature should weigh benefit for sleep against anticholinergic and cardiac signals, especially in older adults.

Clinical Effectiveness In Australia

Patients commonly want to know how quickly doxepin works and who prescribes it locally.

In Australian practice low‑dose doxepin is used for sleep disorders and higher doses for depression or anxiety when SSRIs or SNRIs are unsuitable.

Pharmacists and psychiatrists report sedative effects are seen the first night at insomnia doses, while mood improvement with antidepressant dosing may appear within 1–3 weeks.

PBS listings are limited compared with SSRIs, so prescribing is concentrated in psychiatry, some rural general practice and aged‑care settings.

TGA adverse event reporting commonly lists anticholinergic effects, sedation and dizziness as frequent complaints with doxepin use.

Clinicians manage these by starting low, dosing at night for sedative benefit and reassessing dose every 2–4 weeks during initiation.

Doquel capsules are the commonly supplied Australian brand for standard strengths, with generics available from suppliers such as Mylan and Teva.

Real‑world effectiveness is therefore a balance of rapid nocturnal sedation at 3–6 mg and slower antidepressant response at 75–150 mg per day.

Older patients require lower starting doses and closer monitoring due to higher risk of falls and confusion.

Pharmacists in community chains and local clinics play a key role in counselling on side effects and adherence.

Indications And Expanded Uses

People often ask what doxepin is officially approved for and where it is used off‑label.

On‑label indications reflect antidepressant use at standard doses for major depressive disorder and associated anxiety states.

Low‑dose formulations (3–6 mg) are indicated for insomnia in some jurisdictions, modelled on Silenor tablets used in the United States.

Off‑label uses seen in Australian practice include chronic neuropathic pain management and severe pruritus when other measures fail.

Specialist psychiatrists may use higher doses of doxepin for treatment‑resistant depression as an alternative to other TCAs like amitriptyline or nortriptyline.

Use in adolescents is limited and not recommended for children under 12 years of age without specialist oversight.

Pregnancy and lactation require specialist input because safety data are limited and benefits must outweigh risks.

Typical starting ranges from the Australian product information include 75 mg/day for depression and 3–6 mg at bedtime for insomnia.

Clinicians choose doxepin when sedative properties, neuropathic analgesia or prior patient response favour a TCA over SSRIs.

Shared decision making with clear counselling about anticholinergic effects and cardiac risk is essential.

Composition And Brand Landscape

Patients often ask what is inside a doxepin product and what brand options exist in Australia.

The active moiety is doxepin hydrochloride, classified in ATC under N06AA12 as a tricyclic antidepressant.

In Australia Doquel (Aspen) supplies doxepin capsules in strengths from 10 mg up to 100 mg.

Globally recognised brand names include Sinequan (historical), Silenor (low‑dose insomnia tablets) and generics from Mylan and Teva.

Available dosage forms include capsules (10–100 mg), an oral solution (10 mg/mL) and low‑dose tablets (3 mg, 6 mg) for sleep.

Packaging varies by manufacturer and may include blister packs or bottles depending on the supplier.

Clinicians and pharmacists usually prescribe generics or Doquel in Australia, with PBS listing status varying by formulation and indication.

When supplying for insomnia some prescribers seek Silenor‑style tablets, while deprescribing or switching often uses capsule formulations for titration.

Storage advice is standard: keep at room temperature and in original packaging to protect product integrity.

Contraindications And Special Precautions

Many patients want to know who should not take doxepin and what to watch for.

Absolute contraindications include known hypersensitivity to doxepin or other tricyclic antidepressants, narrow‑angle glaucoma and urinary retention.

Concurrent or recent MAOI use within the previous 14 days is also an absolute contraindication.

Relative contraindications important in Australia include advanced age, severe hepatic or renal impairment and a history of cardiac conduction disorders.

Severe prostatic hypertrophy and a history of suicidality require careful specialist assessment before prescribing doxepin.

Pregnancy and breastfeeding are relative cautions; specialist advice is recommended where benefits outweigh risks.

Indigenous and remote community health services must consider higher comorbidity burdens and medication access challenges when prescribing.

Advise patients to avoid driving or operating heavy machinery until they know how sedation affects them.

Monitoring checkpoints include ECG for those with cardiac history, liver function consideration for hepatic impairment and review for urinary retention.

Dosage Guidelines

People ask how much doxepin they should take for sleep or depression and how to adjust doses safely.

For depression and anxiety the usual adult starting dose is about 75 mg per day, given in divided doses or at night, with typical ranges of 75–150 mg per day.

Specialist supervised doses may reach up to 300 mg per day in treatment‑resistant cases, with close monitoring.

For insomnia low‑dose tablets are used at 3–6 mg at bedtime to gain sedative benefit without full antidepressant exposure.

Elderly patients should start at a lower dose, for example 25–50 mg per day for mood indications, to reduce anticholinergic and sedative effects.

Reduce doses and titrate slowly in hepatic or renal impairment because metabolism and excretion are altered.

Missed doses should be taken when remembered unless close to the next dose, and doubling up is not recommended.

Overdose is potentially life‑threatening with cardiac arrhythmias and seizures and requires immediate medical attention.

Regular review every 2–4 weeks during initiation helps find the minimum effective dose and identify adverse effects early.

Interactions Overview

Patients commonly want a simple list of medicines and substances that interact with doxepin.

Concurrent use of MAO inhibitors within 14 days is contraindicated and can cause severe reactions.

Combining doxepin with other QT‑prolonging drugs increases the risk of cardiac arrhythmias and should be avoided where possible.

Anticholinergic medicines and strong CYP inhibitors may magnify adverse effects, so pharmacist review is important with polypharmacy.

Alcohol and other central nervous system depressants potentiate sedation and respiratory depression and should be avoided or minimised.

My Health Record and PBS dispensing data help Australian prescribers and pharmacists spot interacting prescriptions during review.

When interacting medicines are unavoidable, consider dose reduction, ECG monitoring or alternative therapy depending on the interaction.

Pharmacists in community chains often perform interaction checks at dispensing to reduce risk in older adults with multiple medicines.

Cultural Perceptions And Patient Habits

Many Australians turn to pharmacists first and are price conscious when choosing medicines for sleep or mood.

Chains such as Chemist Warehouse, Priceline and TerryWhite Chemmart are common first points of contact for practical advice about sleep aids.

Rural and remote patients often rely on telehealth e‑prescriptions and pharmacist‑GP collaboration to access doxepin safely.

Older Australians sometimes prefer pharmacological solutions for chronic insomnia, which can drive low‑dose doxepin prescribing.

Indigenous health services prioritise culturally safe care, shared decision making and careful review of comorbidities and polypharmacy.

Online patient forums report good night‑time sleep benefit at low doses but frequent concerns about daytime sedation and dry mouth.

Counselling points should cover expected benefits, common side effects and practical advice about driving, alcohol and workplace safety.

A short rural telehealth vignette helps: a GP in a clinic prescribes low‑dose doxepin 3 mg at night for a patient with chronic insomnia after discussing alternatives and checking other medicines.

Availability And Pricing Patterns

Patients frequently ask where they can buy doxepin and what it costs in Australia.

Doxepin is prescription‑only in Australia and Doquel capsules (10–100 mg) are supplied locally by Aspen with generics also available.

PBS subsidy depends on indication and formulation, so out‑of‑pocket cost varies between PBS‑subsidised and private prescriptions.

Major retail chains and independent pharmacies stock Doquel and generic doxepin, with prices varying between Chemist Warehouse, Priceline and local stores.

Telehealth providers commonly issue electronic prescriptions that community pharmacists can dispense under standard regulations.

Urban centres usually have multiple suppliers and competitive dispensing fees, while rural pharmacies may face stock intermittency and higher fees.

In our online pharmacy, sinequan is available without a prescription, with discreet delivery to Australia in 5-14 days.

When cost is a concern, patients should ask pharmacists about generic options and PBS eligibility to reduce out‑of‑pocket expense.

Comparable Medicines And Preferences

People want to know how doxepin stacks up against other antidepressants and sleep medicines.

SSRIs such as sertraline and fluoxetine are first‑line for depression because they have more favourable side‑effect profiles than TCAs.

Other TCAs like amitriptyline and nortriptyline are alternatives in treatment‑resistant depression and neuropathic pain, and choices are influenced by side‑effect profiles.

Doxepin’s sedative effect can be an advantage for patients with comorbid insomnia, while its anticholinergic burden is a disadvantage in older patients.

For chronic insomnia, low‑dose doxepin may be preferred to benzodiazepines or zolpidem because dependence risk is lower, but daytime sedation still needs monitoring.

Choice should be guided by the patient profile, comorbidities, existing medicines and specific symptom targets such as pain or sleep.

A simple decision matrix helps: younger patient with anxiety → SSRI; older patient with neuropathic pain and insomnia → consider low‑dose doxepin with monitoring; treatment‑resistant depression → TCA under specialist supervision.

FAQ

Is doxepin available over the counter in Australia?

No.

Sinequan, Doquel and generics are prescription‑only and require a valid prescription.

Can I drive while taking doxepin?

Avoid driving until you know how the medicine affects you, particularly because sedation and dizziness are common.

How long until doxepin works?

Night‑time sedation is immediate at insomnia doses and antidepressant effects usually start within 1–3 weeks with continued treatment.

What should I do if I miss a dose or suspect an overdose?

If you miss a dose take it when you remember unless it is near the next scheduled dose; do not double up.

In case of overdose seek immediate medical attention for drowsiness, cardiac symptoms or seizures.

Guidelines For Proper Use

Patients expect clear counselling when receiving doxepin from a pharmacy.

Confirm the indication and dose with the prescriber and explain whether the prescription is for sleep or mood treatment.

Advise nightly dosing for insomnia and divided dosing or night dosing for depression per the prescriber’s plan.

Warn about anticholinergic effects such as dry mouth, constipation and urinary retention and suggest practical measures like hydration and fibre.

Recommend ECG monitoring for patients with cardiac history and liver tests for those with suspected hepatic impairment.

Plan gradual withdrawal to avoid discontinuation symptoms rather than abrupt cessation.

For older patients start at lower doses and discuss falls prevention measures where needed.

Storage guidance: store at room temperature 15–30°C and keep in the original packaging.

Encourage reporting of side effects to the TGA and prompt communication with the GP or pharmacist for any concerning symptoms.

Delivery Across Australia

Final Practical Notes

When considering sinequan or doxepin, always balance the expected benefit for sleep or mood against anticholinergic and cardiac risk factors.

Pharmacists can help check interactions using My Health Record and PBS dispensing history before supply.

Report adverse events to the TGA and seek urgent care for signs of overdose, significant palpitations or new neurological symptoms.

Where cost is a factor ask your pharmacist about Doquel and generic options and whether PBS subsidy applies for your indication.

For remote patients telehealth and electronic prescriptions improve access but confirm local pharmacy stock before finalising an e‑prescription.